NOAELPLATIN - Trademark Details
Status: 700 - Registered
Serial Number
79290136
Registration Number
6398898
Word Mark
NOAELPLATIN
Status
700 - Registered
Status Date
2021-06-29
Filing Date
2020-06-16
Registration Number
6398898
Registration Date
2021-06-29
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2021-04-13
Attorney Name
Law Office Assigned Location Code
M20
Employee Name
SEVERSON, JUSTIN
Statements
Goods and Services
Pharmaceutical preparations for the treatment of pancreatic tumors; pharmaceutical agents for the treatment of disorders in sensory organs; thyroid and para-thyroid hormone preparations; medicinal tonics for the treatment of pancreatic tumors; oral contraceptive pills; antiemetics; local anesthetics; bronchodilating preparations; anti-cough drops; androgen preparations; pituitary hormone preparations; pharmaceutical preparations for treating diabetes; pharmaceutical agents for use in regulating metabolism; vaccines against flu; chilblain preparations; pharmaceutical preparations for headache; anesthetics; pharmaceutical for use in the treating disorders of the peripheral nervous system; pharmaceutical preparations for immunity adjustment; nutritive substances for microorganisms for medical purposes; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparations for treating disorders of the urogenital organs; vitamin preparations; pharmaceutical preparations for the treatment of bone diseases; anti-inflammatory and antipyretic preparations; pharmaceutical agents for treating disorders of the digestive organs; pharmaceutical preparations for the treatment of cardiovascular disorders; nervines; ophthalmic preparations; allergy medications; chemico-pharmaceutical preparations for the treatment of pancreatic disorders; medicines for the treatment of gastrointestinal diseases; mineral injection preparations featuring vitamin supplements for medical purposes; antioxidants for medical purposes; haematogen; pharmaceutical preparations for tumor treatment; multivitamin preparations; laxative suppositories; pharmaceutical preparations for use in the treatment of disorders of the central nervous system; pharmaceutical preparations for diagnosis of cancer; sedatives; analgesics; vaginal washes for medical purposes; pharmaceutical preparations for treating asthma; medicines for treating tooth pain; hemorrhoid preparations; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; vaccines against pneumococcal infections; dermatological pharmaceutical products; contraceptive preparations; antihypertensives; anti-uric preparations; anti-diabetic pharmaceuticals; pharmaceutical preparations for treatment of hemorrhoids; antibiotic preparations; antibiotics; anti-cancer preparations; anti-cancer treatment supplements; antidepressants; anticoagulants; antineoplastics; anti-dermoinfectives; antidotes; antipyretic analgesics; febrifuges; vasoconstrictors; hypoglycemic agents; blood solvent being preparations for treating blood disorders; pharmaceutical preparations for treating disorders of the respiratory organs; respiratory stimulant preparations; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for treating respiratory diseases and asthma; mixed vitamin preparations; preparations for the treatment of burns; disinfectants for chemical toilets; chemotherapeutics; preparations for treatment of hepatitis; preparations for treating colds; preparations for the treatment of hyperlipidemia; preparations for the treatment of hypercholesteremia; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of osteoporosis; preparations for the treatment of osteoporosis; injectable pharmaceuticals for treatment of anaphylactic reactions; pharmaceutical preparations for treating halitosis; nausea treatment preparations; antiulcerants; pharmaceutical preparations for the treatment of musculoskeletal disorders; preparations for the treatment of muscle fatigue; pharmaceutical preparations for treating chloasma; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for the treatment of rhinitis; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; pharmaceutical preparations for the treatment of cancerous cells; medicines for treating intestinal disorders; cardiovascular treatment preparations; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of disorders of the metabolic system; pharmaceutical preparations for treating allergies; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; medicated preparations for the treatment of mouth disorders; transdermal patches for medical treatment of nausea; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of gout; drug delivery agents in the form of dissolvable films, coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents consisting of compounds that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-07-24
Primary Code
005
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Lenny R. Jiang
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1542224
International Registration Date
2020-06-16
International Publication Date
2020-07-23
International Renewal Date
2030-06-16
Auto Protection Date
2022-01-23
International Status
001 - Request for extension of protection established
International Status Date
2020-07-23
Priority Claimed In
True
Priority Claimed Date
2020-06-15
First Refusal In
True
Trademark Events
Event Date | Event Description |
2020-07-23 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2020-07-24 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-07-28 | APPLICATION FILING RECEIPT MAILED |
2020-09-18 | ASSIGNED TO EXAMINER |
2020-09-23 | NON-FINAL ACTION WRITTEN |
2020-09-24 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2020-10-21 | REFUSAL PROCESSED BY MPU |
2020-10-21 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2020-11-08 | REFUSAL PROCESSED BY IB |
2020-12-01 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-03-02 | ASSIGNED TO LIE |
2021-03-04 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-03-04 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-03-09 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2021-03-24 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2021-03-24 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
2021-03-24 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2021-04-12 | NOTIFICATION PROCESSED BY IB |
2021-04-13 | PUBLISHED FOR OPPOSITION |
2021-04-13 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2021-05-19 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
2021-06-29 | REGISTERED-PRINCIPAL REGISTER |
2021-07-12 | REVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED |
2021-09-03 | NEW REPRESENTATIVE AT IB RECEIVED |
2021-09-29 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2021-10-28 | FINAL DISPOSITION PROCESSED |
2021-10-28 | FINAL DISPOSITION NOTICE SENT TO IB |
2021-11-23 | FINAL DECISION TRANSACTION PROCESSED BY IB |